Secondary osteoporosis in women: A retrospective analysis

Archives of Gynecology and Obstetrics

Volumn 266, Issue 4, 2002, Pages 214-217

  Cakir B ^a   Odabasi, E ^a   Turan, M ^a   Guler S ^a   Kutlu, M ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Glucocorticoids; Hyperparathyroidism; Osteoporosis; Secondary osteoporosis; Thyrotoxicosis

Indexed keywords

ALUMINUM DERIVATIVE; ANTACID AGENT; ANTICONVULSIVE AGENT; CYCLOSPORIN A; GLUCOCORTICOID; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; HEPARIN; METHOTREXATE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; PARATHYROID ADENOMA; REFERENCE VALUE; RETROSPECTIVE STUDY; SECONDARY OSTEOPOROSIS; SPINE; STATISTICAL ANALYSIS; THYROTOXICOSIS; TURKEY (REPUBLIC);

ADULT; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERPARATHYROIDISM; MEDICAL RECORDS; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RETROSPECTIVE STUDIES; THYROTOXICOSIS; TURKEY;

EID: 0036919868     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004040100215     Document Type: Article

References (35)

1. Adams JE, Whitehouse RW, Adams PH, Davies M (1990) The effects of primary hyperparathyroidism on trabecular and cortical bone mass. Calcif Tissue Res 46:144
2. Adinoff AD, Hollister JR (1983) Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med 309:265-268
3. American College of Rheumatology Task Force on Osteoporosis Guidelines (1996) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 39:1791-1801
4. Andersson S, Nilsson B (1979) Changes in bone mineral content following ligamentous knee injures. Med Sci Sports 1:351-353
5. Caplan GA, Scane AC, Francis RM (1994) Pathogenesis of vertebral crush fractures in women. J R Soc Med 87:200-202
6. Consensus Development Statement (1997) Who are candidates for prevention and treatment for osteoporosis? Osteoporosis Int 7:1-6
7. Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM (1995) For the Study of Osteoporotic Fractures Research Group, risk factors of hip fracture in white women. N Engl J Med 332:767-773
8. El Maghraovi A, Borderie D, Cherrvav B, Edovard R, Dougados M, Roux C (1999) Osteoporosis, body composition, and bone turnover in ankylosing spondylitis. J Rheumatol 26:2205-2209
9. Greenberger PA, Hendrix RW, Patterson R, Chmiel JS (1982) Bone studies in patients on prolonged systemic corticosteroid therapy for asthma. Clin Allergy 12:363-368
10. Hahn TS, Halstead LR (1979) Anticonvulsant drug-induced osteomalacia alterations in mineral metabolism and response to vitamin D3 administration. Calcif Tissue Int 27:13-18
11. Hahn TS, Birge SJ, Schorp CR, Avioli LV (1972) Phenobarbital induced alterations in vitamin D metabolism. J Clin Invest 51:741-748
12. Haugeberg G, Unlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female with rheumatoid arthritis: results from 349 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522-530
13. Kanis JA (1997) Causes of osteoporosis. In: Kanis JA (ed) Osteoporosis. Blackwell Healthcare, London, pp 99-100
14. Kanis JA, Melton LJ III, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9:1137-1141
15. Khosla S, Lufkin EG, Hodgkson SF, Fitzpatrick LA, Melton LJ III (1994) Epidemiology and clinical features of osteoporosis in young individuals. Bone 15:551-555
16. Kleerekoper M, Avioli L (1993) Primer on the metabolic bone diseases and disorders of mineral metabolism. In: Favus MJ (ed) Evaluation and treatment of postmenopausal osteoporosis. Lippincott-Raven, New York, p 223
17. Krolner B, Toft B (1983) Vertebral bone loss: an unheeded side effects of therapeutic bed rest. Clin Sci 64:573-540
18. Krolner B, Jorgensen VJ, Nielsen SP (1983) Spinal bone mineral content in myxedema and thyrotoxicosis: effects of thyroid hormone(s) and antithyroid treatment. Clin Endocrinol 18:439-446
19. Lee MS, Kim SY, Lee MC (1990) Negative correlation between the change in bone mineral density and serum osteocalcin in patients with hyperthyroidism. J Clin Endocrinol Metab 70:766-770
20. Meirelles ES, Borelli A, Camargo OP (1999) Influence of disease activity and chronicity on ankylosing spondylitis bone mass loss. Clin Rheumatol 18:364-368
21. Melton LJ III (1995) How many women have osteoporosis now? J Bone Miner Res 10:175-177
22. Melton LJ III, Atkinson EJ, Khosla S, O'Fallon WM, Riggs BL (1999) Secondary osteoporosis and the risk of vertebral deformities in women. Bone 24:49-55
23. Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormone on bone mineral metabolism. Endocrinol Metab Clin North Am 19:35-63
24. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
25. Pfeilschifter J, Siegrist E, Wuster C, Blind E, Ziegler R (1992) Serum levels of intact parathormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism. Acta Endocrinol 127:319-323
26. Possi-Mucelli RS, Kanter AS, Genant HK, Cann CE, Ettinger B, Kolb FO (1983) Quantitative bone mineral analyses in primary hyperparathyroidism. J Comput Assist Tomogr 7:555
27. Raisz LG, Kream BE, Lorenzo JA (1998) Metabolic bone disease. In: Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds) Williams textbook of endocrinology, 9th edn. Saunders, Philadelphia, pp 1211-1239
28. Reid DM, Nicoll JJ, Smith MA, Higgins B, Tothill P, Nuki G (1986) Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. BMJ 293:1463-1466
29. Riggs BL, Melton LJ III (1995) The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone 17:505- 511
30. Rush R, Wong J, Kirsh J, Deulin M (1994) Osteopenia in patients with above knee amputation. Arch Phys Med Rehabil 75:112-115
31. Schlechte JA, Sherman B, Martin R (1983) Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab 56:1120-1123
32. Schlechte J, Walkner L, Kathol M (1992) A longitudinal analysis of premenopausal bone loss in healthy women with hyperprolactinemia. J Clin Endocrinol Metab 75:698-703
33. Solomon BL, Wartofsky L, Burman KD (1993) Prevalance of fractures in postmenopausal women with thyroid disease. Thyroid 3:17-23
34. Toh SH, Claunch BC, Brown PH (1985) Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 145:883-886
35. Westhovens R, Dequehers J (2000) Rheumatoid arthritis and osteoporosis. Rheumatol [Suppl 1] 59:33-38